Prediction of 5-year overall survival of diffuse large B-cell lymphoma on the pola-R-CHP regimen based on 2-year event-free survival and progression-free survival.
Zhang WR, Liu X, Zhong QZ, Wu T, Yang Y, Chen B, Jing H, Tang Y, Jin J, Liu YP, Song YW, Fang H, Lu NN, Li N, Zhai YR, Zhang WW, Wang SL, Chen F, Yin L, Qi SN, Li YX.
Zhang WR, et al.
Cancer Med. 2024 Jan 5;13(1):e6899. doi: 10.1002/cam4.6899. Online ahead of print.
Cancer Med. 2024.
PMID: 38180169
Free PMC article.